NEW YORK, May 17, 2024 /PRNewswire/ -- The global sex reassignment surgery market in us  size is estimated to grow by USD 125.78 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  10.84%  during the forecast period. 

For more insights on the forecast market size and historic data (2017 - 2021) - Download Free sample report in minutes 

Key Market Trends Fueling Growth

The sex reassignment surgery market in the US has witnessed significant growth due to increased transgender visibility through social media and societal acceptance. Transgender individuals, particularly those transitioning, require comprehensive care, including fertility consultations for preservation and counseling for gender identity exploration. Various gender-affirming surgical procedures are available, such as orchiectomy, ovariectomy, vaginoplasty, chest masculinization surgery, and facial feminization surgery. Innovations continue in metoidioplasty, phalloplasty, and scrotoplasty. Medicare and Medicaid programs cover some of these procedures for transgender beneficiaries. Hospitals like Mount Sinai and clinics such as the Transgender Surgery Institute offer gender-affirming surgeries. 

Market Challenges

• The sex reassignment surgery market in the US faces challenges due to potential complications from procedures such as facial, top, and bottom surgeries for transgender males and females. Adverse effects include vaginal closure, skin graft rejection, and urinary issues. Rare cases may result in major complications. Common risks include bleeding, infection, and anesthetic side effects. Other gender-affirming care, like hormone therapy and mental health support, are essential components of the transgender population's overall health and well-being. The public health challenge of gender dysphoria requires equitable access to surgical techniques and medical services, including chest surgery, chin augmentation, and facial feminization surgery. Technological innovation and societal stigma also impact the growth of this market.

Research report provides comprehensive data on impact of trend, driver and challenges - Buy Report

Segment Overview 

This sex reassignment surgery market in US report extensively covers market segmentation by

1. Type 
   • 1.1 Male to female
   • 1.2 Female to male
2. End-user 
   • 2.1 Hospitals
   • 2.2 Clinics
3. Geography 
   • 3.1 North America

1.1 Male to female-  The Sex Reassignment Surgery (SRS) market in the US is primarily segmented into two categories: transgender males and transgender females, each with unique requirements for gender dysphoria transition. Hospitals specializing in gender affirmation surgeries offer various procedures for these populations, including hysterectomy, salpingo-oophorectomy, orchiectomy, ovariectomy, and mastectomy for transgender females, and phalloplasty, scrotoplasty, and chest masculinization surgery for transgender males. The young transgender population also seeks SRS, with procedures such as reduction thyrochondroplasty for voice feminization and vaginoplasty for neo-vagina creation. The Obamacare legislation and Medicaid program have expanded coverage for transgender beneficiaries, increasing access to gender-affirming care. Key surgical procedures include hysterectomy, orchiectomy, and vaginoplasty, while augmentation mammoplasty, breast reduction, and facial feminization surgery cater to the transfeminine population. Transgender issues continue to evolve, with ongoing research and development in SRS techniques.

For more information on market segmentation with geographical analysis including forecast (2023-2027) and historic data (2017 - 2021)  - Download a Sample Report

Research Analysis

The Sex Reassignment Surgery (SRS) market in the US has witnessed significant growth, driven by the increasing number of transgender individuals seeking gender dysphoria treatment. This cohort includes transgender males and females, particularly among the young population. Gender dysphoria transition often involves self-identified gender exploration and the pursuit of gender-affirming interventions such as Gender-confirming surgeries and hormone therapy. Gender-affirming surgeries encompass various procedures, including genital reconstructive procedures for transgender males and chest surgery (mastectomy) and facial feminization surgery for transgender females. Clinicians play a crucial role in providing mental health support and guiding patients through the temporal trends of SRS. Hormone therapy and gender-confirming surgeries have become increasingly accepted medical interventions for transgender individuals. The National Inpatient Sample provides valuable insights into the utilization and outcomes of these procedures. Overall, the SRS market continues to expand, reflecting the growing recognition and acceptance of transgender individuals and their unique healthcare needs.

Market Research Overview

The Sex Reassignment Surgery (SRS) market in the US has been witnessing significant growth due to increasing acceptance and recognition of gender diversity. The market encompasses various procedures such as orchiectomy, vaginoplasty, and phalloplasty, among others. These surgeries aim to help individuals align their physical identity with their gender identity. The market is driven by factors like growing awareness and acceptance of transgender and gender non-conforming individuals, advancements in surgical techniques, and improved access to healthcare. The market also faces challenges like high costs, lack of insurance coverage, and stigma associated with gender diversity. The market is segmented based on procedures, regions, and end-users. The future outlook of the market is promising with increasing acceptance and recognition of gender diversity and advancements in surgical techniques.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Type
• • Male To Female
  • Female To Male
• End-user
• • Hospitals
  • Clinics
• Geography
• • North America

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/sex-reassignment-surgery-market-in-us-size-is-set-to-grow-by-usd-125-78-mn-from-2023-2027--increase-in-number-of-people-opting-for-sex-change-surgeries-in-us-to-boost-the-market-growth-technavio-302147931.html

SOURCE Technavio